PMID- 25658431 OWN - NLM STAT- MEDLINE DCOM- 20160108 LR - 20220129 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 10 IP - 2 DP - 2015 TI - Sub-cellular localisation studies may spuriously detect the Yes-associated protein, YAP, in nucleoli leading to potentially invalid conclusions of its function. PG - e0114813 LID - 10.1371/journal.pone.0114813 [doi] LID - e0114813 AB - The Yes-associated protein (YAP) is a potent transcriptional co-activator that functions as a nuclear effector of the Hippo signaling pathway. YAP is oncogenic and its activity is linked to its cellular abundance and nuclear localisation. Activation of the Hippo pathway restricts YAP nuclear entry via its phosphorylation by Lats kinases and consequent cytoplasmic retention bound to 14-3-3 proteins. We examined YAP expression in liver progenitor cells (LPCs) and surprisingly found that transformed LPCs did not show an increase in YAP abundance compared to the non-transformed LPCs from which they were derived. We then sought to ascertain whether nuclear YAP was more abundant in transformed LPCs. We used an antibody that we confirmed was specific for YAP by immunoblotting to determine YAP's sub-cellular localisation by immunofluorescence. This antibody showed diffuse staining for YAP within the cytosol and nuclei, but, noticeably, it showed intense staining of the nucleoli of LPCs. This staining was non-specific, as shRNA treatment of cells abolished YAP expression to undetectable levels by Western blot yet the nucleolar staining remained. Similar spurious YAP nucleolar staining was also seen in mouse embryonic fibroblasts and mouse liver tissue, indicating that this antibody is unsuitable for immunological applications to determine YAP sub-cellular localisation in mouse cells or tissues. Interestingly nucleolar staining was not evident in D645 cells suggesting the antibody may be suitable for use in human cells. Given the large body of published work on YAP in recent years, many of which utilise this antibody, this study raises concerns regarding its use for determining sub-cellular localisation. From a broader perspective, it serves as a timely reminder of the need to perform appropriate controls to ensure the validity of published data. FAU - Finch, Megan L AU - Finch ML AD - School of Chemistry and Biochemistry, University of Western Australia, Crawley, Western Australia, 6009, Australia. FAU - Passman, Adam M AU - Passman AM AD - School of Chemistry and Biochemistry, University of Western Australia, Crawley, Western Australia, 6009, Australia. FAU - Strauss, Robyn P AU - Strauss RP AD - School of Chemistry and Biochemistry, University of Western Australia, Crawley, Western Australia, 6009, Australia. FAU - Yeoh, George C AU - Yeoh GC AD - School of Chemistry and Biochemistry, University of Western Australia, Crawley, Western Australia, 6009, Australia; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, the University of Western Australia, Crawley, Western Australia, 6009, Australia. FAU - Callus, Bernard A AU - Callus BA AD - School of Chemistry and Biochemistry, University of Western Australia, Crawley, Western Australia, 6009, Australia. LA - eng GR - 09-0084/AICR_/Worldwide Cancer Research/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150206 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Cell Cycle Proteins) RN - 0 (Phosphoproteins) RN - 0 (Transcription Factors) RN - 0 (YAP-Signaling Proteins) RN - 0 (YAP1 protein, human) RN - 0 (Yap1 protein, mouse) SB - IM MH - Adaptor Proteins, Signal Transducing/genetics/*metabolism MH - Animals MH - Cell Cycle Proteins MH - Cell Line MH - Cell Nucleolus/genetics/*metabolism MH - Humans MH - Mice MH - Phosphoproteins/genetics/*metabolism MH - Protein Transport/physiology MH - Transcription Factors MH - YAP-Signaling Proteins PMC - PMC4320119 COIS- Competing Interests: The financial support from the funders does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. EDAT- 2015/02/07 06:00 MHDA- 2016/01/09 06:00 PMCR- 2015/02/06 CRDT- 2015/02/07 06:00 PHST- 2014/07/16 00:00 [received] PHST- 2014/11/04 00:00 [accepted] PHST- 2015/02/07 06:00 [entrez] PHST- 2015/02/07 06:00 [pubmed] PHST- 2016/01/09 06:00 [medline] PHST- 2015/02/06 00:00 [pmc-release] AID - PONE-D-14-31786 [pii] AID - 10.1371/journal.pone.0114813 [doi] PST - epublish SO - PLoS One. 2015 Feb 6;10(2):e0114813. doi: 10.1371/journal.pone.0114813. eCollection 2015.